Analyst Ratings for Bio-Rad Labs (BIO)
BIO Rating Summary
BIO Price Target Summary
- Highest: $370.00 (RBC Capital)
- Lowest: $300.00 (Citi)
- Average: $333.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$333.33 (-11.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
Avg. $ Target:
$333.33 (-11.6%)
* Over Last 12-Mos
Rating Score: 6 / 10
Percentile Rank: 63%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/14/2026 | RBC Capital » Updated 8/5/2026 |
Dan Leonard | New Coverage | Outperform (N/A) |
370.00 (320.00) |
243.51 (376.97) |
54.81% | Details |
| 4/7/2026 | Citi | Patrick Donnelly | Downgrade | Neutral (Buy) |
300.00 (375.00) |
278.85 (376.97) |
35.19% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
